Touba Eslaminejad
- Molecular Biology
- Biomaterials top 10%
- Biomedical Engineering
- Pollution top 10%
- Molecular Medicine top 10%
- Co-authors
- Mehdi AnsariSeyed Noureddin Nematollahi‐MahaniMandana OhadiGholamreza DehghannoudehMojtaba ShakibaieHamid ForootanfarArash Shahravanİbrahim M. Banat
- Topics
- RNA Interference and Gene Delivery (6 papers)Nanoparticle-Based Drug Delivery (5 papers)Advanced Drug Delivery Systems (5 papers)
- Journals
- SHILAP Revista de lepidopterologíaJournal of Magnetism and Magnetic MaterialsCell and Tissue Research
In The Last Decade
Touba Eslaminejad
31 papers receiving 527 citations
Peers
Comparison fields: 5 of 94
- Molecular Biology 206
- Biomaterials 113
- Biomedical Engineering 101
- Pollution 97
- Molecular Medicine 60
Countries citing papers authored by Touba Eslaminejad
This map shows the geographic impact of Touba Eslaminejad's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Touba Eslaminejad with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Touba Eslaminejad more than expected).
Fields of papers citing papers by Touba Eslaminejad
This network shows the impact of papers produced by Touba Eslaminejad. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Touba Eslaminejad. The network helps show where Touba Eslaminejad may publish in the future.
Co-authorship network of co-authors of Touba Eslaminejad
This figure shows the co-authorship network connecting the top 25 collaborators of Touba Eslaminejad. A scholar is included among the top collaborators of Touba Eslaminejad based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Touba Eslaminejad. Touba Eslaminejad is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 5 | |
| 2 | 1 | |
| 3 | 3 | |
| 4 | 0 | |
| 5 | 39 | |
| 6 | 6 | |
| 7 | 18 | |
| 8 | 27 | |
| 9 | 5 | |
| 10 | 75 | |
| 11 | 15 | |
| 12 | 16 | |
| 13 | 54 | |
| 14 | 11 | |
| 15 | 30 | |
| 16 | 26 | |
| 17 | 12 | |
| 18 | 8 | |
| 19 | 23 | |
| 20 | 18 |
About Touba Eslaminejad
Touba Eslaminejad is a scholar working on Pharmaceutical Science, Biomaterials and Molecular Medicine, having authored 32 papers that have together received 535 indexed citations. Recurring topics across this work include RNA Interference and Gene Delivery (6 papers), Nanoparticle-Based Drug Delivery (5 papers) and Advanced Drug Delivery Systems (5 papers). The work is most often cited by research in Molecular Medicine (60 citations), Pharmaceutical Science (58 citations) and Biomaterials (113 citations). Touba Eslaminejad has collaborated with scholars based in Iran, Malaysia and Canada. Frequent co-authors include Mehdi Ansari, Seyed Noureddin Nematollahi‐Mahani, Mandana Ohadi, Gholamreza Dehghannoudeh, Mojtaba Shakibaie, Hamid Forootanfar, Arash Shahravan, İbrahim M. Banat, Atefeh Ameri and Mahboubeh Adeli‐Sardou. Their work appears in journals such as SHILAP Revista de lepidopterología, Journal of Magnetism and Magnetic Materials and Cell and Tissue Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.